C. L. Goodfellow

Discovery and characterization of the potent, selective and orally bioavailable MMP inhibitor ABT-770.

S. Davidsen, M. Michaelides, P. Tapang, 2001, Bioorganic & Medicinal Chemistry Letters.

Biaryl ether retrohydroxamates as potent, long-lived, orally bioavailable MMP inhibitors.

S. Davidsen, M. Michaelides, D. Albert, 2001, Bioorganic & medicinal chemistry letters.

Aryl ketones as novel replacements for the C-terminal amide bond of succinyl hydroxamate MMP inhibitors.

S. Davidsen, D. Albert, J. Summers, 1998, Bioorganic & medicinal chemistry letters.

Phenoxyphenyl sulfone N-formylhydroxylamines (retrohydroxamates) as potent, selective, orally bioavailable matrix metalloproteinase inhibitors.

Yan Guo, Yujia Dai, S. Davidsen, 2002, Journal of medicinal chemistry.